Peter Grant will join LiDCO, the haemodynamic monitoring company, as non-executive director and chairman designate on 6 March 2017.

He will replace Theresa Wallis, the current chairman, when she steps down from the board at the 2017 annual general meeting (AGM). Ian Brown, the current non-executive director also intends to step down at the AGM.

Grant was previously chief executive of Skyepharma from January 2012 to June 2016 until its merger with Vectura Group. He first joined Skyepharma as chief financial officer in November 2006.

In addition, Jill McGregor will join LiDCO’s board as chief financial officer by 3 July 2017 or earlier. The current incumbent, Paul Clifford, will retire at the end of March, and LiDCO will appoint David Parry as interim head of finance until McGregor’s arrival.

McGregor joins from Touch Bionics, a UK-based provider of upper limb technologies (recently acquired by Ossur), where she was chief financial officer for six years. She is a chartered accountant with over 25 years’ experience in a number of finance roles.

Matt Sassone, chief executive officer of LiDCO since August 2015, said: "I am very pleased to be welcoming Peter and Jill to the board of LiDCO and we look forward to benefitting from their breadth of experience as we enter the next stage of the company’s growth. I would like to extend my thanks to Theresa, Ian and Paul for all of their support and guidance during my first 19 months as chief executive."